Comparison of the effects of a new anticholinergic drug (AA 28-263, Sandoz) and terbutaline in a dose-response study in endogenous asthmatics.
D000328:Adult; D000336:Aerosols; D000403:Airway Resistance / Q000187:drug effects; D001249:Asthma / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D003988:Dibenzothiepins / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005541:Forced Expiratory Volume; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D010276:Parasympatholytics / Q000009:adverse effects / Q000627:therapeutic use*; D013726:Terbutaline / Q000009:adverse effects / Q000627:therapeutic use*; D014202:Tremor / Q000139:chemically induced
D000336:Aerosols; D003988:Dibenzothiepins; D010276:Parasympatholytics; C041681:SAN AA 28-263; D013726:Terbutaline